Robert F. Kennedy Jr., President Trump’s pick to run the Department of Health and Human Services, squared off with Democratic ...

A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need treatment for ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot ...

There are precedents for a hybrid NHS-private model of healthcare. Ten years ago, a new drug treatment arrived that could ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...

An experimental drug called amycretin showed signs it could be more potent than Eli Lilly’s rival Zepbound, though analysts ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

Back pain is among the most common forms of pain patients endure, and can severely alter their quality of life and ability to ...